Behavioral Interventions for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how effectively a new tool, T2.coach, helps people manage type 2 diabetes. It compares two groups: one receiving regular care and another using T2.coach for six months. The trial focuses on personalizing diabetes management based on individual behavior and blood sugar patterns. People with type 2 diabetes who have been patients at participating health centers for at least six months and regularly attend diabetes education may be a good fit. Participants must have a smartphone and speak English or Spanish. As an unphased trial, this study offers a unique opportunity to contribute to innovative diabetes management strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on behavioral interventions, so you may not need to change your medication routine.
What prior data suggests that this behavioral intervention is safe for managing type 2 diabetes?
Research has shown that the T2.coach program is safe for people with type 2 diabetes. Users have not reported any major safety issues. In one study, participants who followed this health coaching program for over six months experienced health improvements, with blood sugar levels dropping by about 0.57%. This suggests that the program is not only effective but also easy to use over time. Overall, evidence indicates that T2.coach is a safe way to help manage type 2 diabetes.12345
Why are researchers excited about this trial?
Researchers are excited about T2.coach because it offers a personalized digital approach to managing Type 2 Diabetes. Unlike traditional treatments that focus solely on medication and standard education, T2.coach integrates tailored behavioral interventions through a digital platform. This innovative method aims to enhance patient engagement and adherence by providing real-time feedback and support, potentially leading to better long-term outcomes. By leveraging technology, T2.coach addresses the daily challenges of diabetes management in a more interactive and supportive way.
What evidence suggests that T2.coach is effective for managing type 2 diabetes?
Studies have shown that blended-care approaches, such as the T2.coach app, effectively manage type 2 diabetes. These studies reported improvements in users' health. In this trial, participants in the T2.coach arm will receive standard care and access to the T2.coach app for 6 months. T2.coach is a mobile app designed to help people manage their diabetes more effectively. Research indicates that apps with online coaching can lead to better blood sugar control. Additionally, users have found T2.coach to be a reliable tool for managing their condition.13678
Who Is on the Research Team?
Olena Mamykina, PhD
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with type 2 diabetes, an HbA1c level of at least 8.0, who own a mobile phone and speak English or Spanish. They must be patients at the health center for over six months and attend its diabetes education program. Those with severe cognitive issues, pregnancy, participation in similar past trials, serious illnesses like advanced cancer or heart failure, or plans to leave the health center within a year cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive standard diabetes education and the experimental group uses T2.coach for 6 months
Follow-up
Participants are monitored for changes in diabetes self-efficacy, problem-solving, and HbA1c levels
What Are the Treatments Tested in This Trial?
Interventions
- T2.coach
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
University of Colorado, Denver
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Clinical Directors Network
Collaborator